<html>
<head>PUBMED IDs for SH3KBP1</head>
<body bgcolor='#C5F0F2'><h1>SH3KBP1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16978157/'>Phosphorylation of the proline-rich domain of Xp95 modulates Xp95 interaction with partner proteins.</a> September 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/21830225/'>SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.</a> January 31  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22037207/'>SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter.</a> June 7  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22984654/'>Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease.</a> September 18  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22984631/'>LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.</a> March 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25472714/'>SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR.</a> March 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26206335/'>Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer.</a> August 2  2015<br></body></html>
